Nxera Pharma Co., Ltd. (TYO: 4565)
Japan
· Delayed Price · Currency is JPY
1,137.00
+17.00 (1.52%)
Nov 21, 2024, 3:45 PM JST
Nxera Pharma Employees
Nxera Pharma had 350 employees as of December 31, 2023. The number of employees increased by 148 or 73.27% compared to the previous year.
Employees
350
Change (1Y)
148
Growth (1Y)
73.27%
Revenue / Employee
78.70M JPY
Profits / Employee
-9.98M JPY
Market Cap
102.22B
Employees Chart
Nxera Pharma News
- 9 days ago - Nxera Pharma's Partner Centessa Initiates Phase 2 Trial with ORX750, a Novel Orexin Receptor 2 (OX2R) Agonist - GlobeNewsWire
- 16 days ago - Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI - GlobeNewsWire
- 20 days ago - Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2024 - GlobeNewsWire
- 4 weeks ago - Nxera Pharma Wins Biotech Company of the Year and Financing Deal of the Year at the Citeline Japan Awards 2024 - GlobeNewsWire
- 4 weeks ago - Nxera Pharma to Host R&D Day 2024 - GlobeNewsWire
- 7 weeks ago - Nxera Pharma Appoints Experienced Commercial R&D Executive Makoto Sugita as Chief Medical Officer and President of Nxera Pharma Japan - GlobeNewsWire
- 7 weeks ago - Nxera Pharma Enters New Commercial Partnership with Shionogi for QUVIVIQ™ in Japan - GlobeNewsWire
- 2 months ago - Nxera Pharma Receives Approval of QUVIVIQ (daridorexant) 25 and 50 mg in Japan for the Treatment of Insomnia - GlobeNewsWire